Clinical Trial Update: Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating dose-response and safety of Cofact under vitamin K antagonist anticoagulation in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Cofact

Snippet

Sponsor: Prothya Biosolutions | Conditions: Healthy Volunteers | Phase 1, Phase 2 | Status: COMPLETED